Eurand to Present at Pacific Growth Equities 2005 Life...
06.06.2005 / 08:23 / Rubriek: Informatief / Organisatie: Eurand
Eurand to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference
MILAN, Italy, June 6/PRNewswire/ --
Eurand announced today that Gearoid Faherty, Chairman and CEO, will present an overview of the company at the 2005 Life Sciences Growth Conference sponsored by Pacific Growth Equities on Tuesday, June 7, 2005. The presentation will be held at the Mark Hopkins InterContinental Hotel in San Francisco, California, at 2:00 p.m. PDT.
Eurand is a privately held specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug delivery technologies. The Company specializes in four areas: bioavailability enhancement of poorly soluble drugs, customized release, taste masking/fast-dissolving formulations, and drug targeting. Eurand has had three products approved by the FDA since 2000 and is currently developing a pipeline of products based on its proprietary drug delivery technology. The company also works with many of the world's leading pharmaceutical and biotechnology companies to develop enhanced forms of their existing products and development compounds.
Eurand is a global company with more than 500 employees and annual revenue of more than US$100 million. Eurand is based in Milan, Italy, with research, development and manufacturing facilities throughout the world, including sites in Milan, Italy; Dayton, Ohio (US) and Paris, France. Eurand has partnered with Warburg Pincus, one of the world's leading private equity firms. For more information, visit Eurand's website at www.eurand.com.
Web site: www.eurand.com
Source: Eurand
Gearoid Faherty, CEO, Eurand, (Italy) +39-02-954281, bizdev@eurand.com; John Capodanno, Financial Dynamics, +1-212-850-5705, for Eurand